DRS — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-07-30

• Our revenue generation of $1,759 million for the six months ended June 30, 2026 represents an increase of $131 million, or 8.0%, as compared to the six months ended June 30, 2025. The revenue increase is primarily attributed to conversion of our funded backlog along with higher demand across each of…

• Cost of revenues increased by $44 million, or 7.0%, to $676 million for the three months ended June 30, 2026, as compared to $632 million for the three months ended June 30, 2025. The cost of revenues increase was due to the increased revenue contribution realized during the period. This increase wa…

• Cost of revenues increased by $60 million, or 4.8%, to $1,310 million for the six months ended June 30, 2026, as compared to $1,250 million for the six months ended June 30, 2025. The cost of revenues increase was due to the increased revenue contribution realized during the period. This increase wa…

• Gross profit increased by $40 million, or 20.3%, to $237 million for the three months ended June 30, 2026 and increased by $71 million, or 18.8%, to $449 million for the six months ended June 30, 2026, as compared to the same periods in the prior year, resulting from the revenue and cost of revenues…

• G&A expenses increased by $8 million, or 6.6%, for the three months ended June 30, 2026, as compared to the three months ended June 30, 2025, primarily due to increased IR&D expenditures and costs related to bid and proposal efforts for new contractual pursuits.

Text removed vs the prior filing · source: 10-Q · 2026-05-05

• Cost of revenues increased by $16 million, or 2.6%, to $634 million for the three months ended March 31, 2026 as compared to $618 million for the three months ended March 31, 2025. The cost of revenues increase was due to the increased revenue contribution realized during the period. This increase w…

• Gross profit increased by $31 million, or 17.1%, to $212 million for the three months ended March 31, 2026 as compared to the same period in the prior year, resulting from the revenue and cost of revenues trends noted above. The gross profit increase, favorable mix and overall program performance dr…

• G&A expenses increased by $13 million, or 11.1%, for the three months ended March 31, 2026 as compared to the three months ended March 31, 2025, primarily due to increased IR&D expenditures and costs related to bid and proposal efforts for new contractual pursuits.

• Amortization of acquired intangible assets was consistent for the three months ended March 31, 2026 as compared to the three months ended March 31, 2025.

• Operating earnings increased by $18 million to $77 million for the three months ended March 31, 2026 as compared to the same period in the prior year. The increase was driven by the gross profit impacts offset in part by the G&A expense increases noted above.

Text added vs the prior filing · source: 10-Q · 2026-07-30

• During the three months ended June 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as such terms are defined under Item 408 of Regulation S-K.

Text removed vs the prior filing · source: 10-Q · 2026-05-05

• The following table includes the material terms (other than with respect to the price) of each Rule 10b5-1 Plan adopted or terminated by our executive officers and directors during the quarter ended March 31, 2026(1):

• Aggregate number of shares of common stock to be purchased or sold(4)(5)

• Jason Rinsky, Executive Vice President, Chief Tax and Treasury Officer

• Michael Dippold, Executive Vice President, Chief Financial Officer

• Mark Dorfman, Executive Vice President, General Counsel & Secretary